September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global clinical trial management system market size is expected to surge to around USD 7.28 billion by 2035 from USD 2.56 billion in 2026, with a CAGR of 12.36%.
September 2026
The global AI-based clinical trials solution provider market size is estimated to surpass around USD 20.17 billion by 2035 from USD 3.52 billion in 2026, at a CAGR of 21.49%.
September 2026
The global automotive active safety systems market size is expected to be worth around USD 297.97 billion by 2035 from USD 138.72 Bn in 2026 with a CAGR of 8.88%.
September 2026
The mental health clinical trials market size was valued at USD 3.72 billion in 2026 and is projected to surge around USD 7.00 billion by 2034, with a CAGR of 8.24%.
September 2026
The clinical decision support systems market size is predicted to hit around USD 8.70 billion by 2035 from USD 4.28 billion in 2026 with a CAGR of 8.22%.
September 2026
The global stem cell banking market size was valued at USD 8.93 billion in 2026 and is expected to surpass around USD 27.71 billion by 2034 with a CAGR of 15.29%.
September 2026
The neurology clinical trials market size was valued at USD 6.57 billion in 2026 and is projected to reach around USD 10.14 billion by 2034 with a CAGR of 5.58%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global stem cell manufacturing market size reached USD 17.57 billion in 2026 and is projected to surpass around USD 45.38 billion by 2035, with a solid CAGR of 11.13%.
September 2026
The global stem cells market surpassed USD 20.79 Bn in 2026 and is projected to cross USD 53.32 Bn by 2035, growing at a CAGR of 11.08% from 2026 to 2035.
September 2026
The global automotive active health monitoring system market size is predicted to hit USD 68.31 billion by 2035 and to grow at a CAGR of 26.66% from 2026 to 2035.
September 2026
The global clinical trials market size is calculated at USD 91.66 billion in 2026 and is projected to hit around USD 158.92 billion by 2035, with a solid CAGR of 6.15%.
September 2026
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
September 2026
The U.S. clinical trial management system market size was evaluated at USD 910 million in 2026 and is predicted to hit around USD 2,400 million by 2034, growing at a CAGR of 12.79%.
September 2026
The biopharma clinical trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The generative AI in clinical trials market size was USD 303.39 billion in 2026, with leading generative AI in clinical trials market players including IBM, Microsoft, Google Health, IQVIA, Parexel, ICON plc.
September 2026
The synthetic stem cells market size stood at USD 11.25 billion in 2026, with major synthetic stem cells market companies including Brainstorm Cell Therapeutics, Fate Therapeutics, Evotec, Cesca Therapeutics, VistaGen Therapeutics.
September 2026
The non-clinical information systems market reached USD 19.69 billion in 2026, with key non-clinical information systems market companies including Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, Epic Systems Corporation.
September 2026
The hematopoietic stem cell transplantation market size reached USD 12.69 billion in 2026, with leading hematopoietic stem cell transplantation market companies including Novartis, Gilead Sciences, Baxter International, Fresenius Kabi.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The decentralized clinical trials in neurology market size reached USD 1.71 billion in 2026, with leading decentralized clinical trials in neurology market companies including IQVIA, ICON plc, Parexel, Medpace.
September 2026
The CNS clinical trials market size reached USD 9.33 billion in 2026, with leading CNS clinical trials market companies including IQVIA, ICON plc, Labcorp Drug Development, Syneos Health.
September 2026
The global cancer stem cells market size is anticipated to worth around USD 6.60 billion by 2034 from USD 2.69 billion in 2026 with a CAGR of 11.92%.
September 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
September 2026
The global stem cell transplantation market growth is driven by rising cancer cases, advances in regenerative medicine, and increasing stem cell research.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
The stem cell umbilical cord blood market size totalled USD 18.57 billion in 2025, with major stem cell umbilical cord blood market players including Cord Blood Registry (CBR), Cryo-Cell International, Inc., ViaCord (PerkinElmer), Global Cord Blood Corporation.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com